Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Edward Kirk Barnes

Dr. Edward Kirk Barnes

Medical Oncologist

Dr. Edward Kirk Barnes is a respected medical oncologist who treats a variety of adult cancers, including malignant mesothelioma, for the Tennessee Oncology group in Nashville.

Get in touch
Jump to a Topic:

About Edward Kirk Barnes

  • Heated Chemotherapy icon

    Heated Chemotherapy

  • Board Certified icon

    Board Certified in Medical Oncology

Get to Know Dr. Edward Kirk Barnes

Medical oncologist Dr. Edward Kirk Barnes handles chemotherapy treatment for malignant mesothelioma patients at the TriStar Skyline Medical Center and the TriStar Centennial Medical Center.

Barnes specializes in hematology with Tennessee Oncology, a community based group of specialists with convenient locations throughout the area.

He also is affiliated with the Sarah Cannon Research Institute, which allows him to utilize the latest treatment advances for his patients.

With more than 20 years of experience, Barnes treats a wide range of adult malignancies, including lung cancer, malignant mesothelioma, blood cancers and leukemia.

Barnes works closely with Dr. Michel Kuzur and Dr. David Spigel at Tennessee Oncology. They coordinate their efforts to provide the best possible treatment for each patient.

Specialties of Dr. Edward Kirk Barnes

  • Internal medicine
  • Hematology
  • Chemotherapy
  • Bone marrow biopsies
  • Blood transfusions

Dr. Edward Kirk Barnes’ Experience and Medical Education

  • Tennessee Oncology
  • Vanderbilt University School of Medicine (Fellowship)
  • Saint Thomas Midtown Hospital (Internship and residency)
  • University of Tennessee College of Medicine (Medical degree)

Awards and Other Recognitions

  • Healthgrades Honor Roll
  • Patient Safety Award
  • Nashville Academy of Medicine

See More Top Mesothelioma Doctors

Publications of Dr. Edward Kirk Barnes

  • Bendell, J. et al. (2017, April 20). A Phase-2 Trial of Single Agent Axitinib as Maintenance Therapy Following First-Line Treatment With Modified FOLFOX/Bevacizumab in Patients With Metastatic Colorectal Cancer. Epub.
  • Spigel, D. et al. (2012). Phase II Study of Bevacizumab and Chemoradiation in the Preoperative or Adjuvant Treatment of Patients With Stage II/III Rectal Cancer. Clinical Colorectal Cancer.

Disclaimer: Dr. Edward Kirk Barnes has no professional affiliation with

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer. Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Fran Mannino, editor for The Mesothelioma Center
Edited by

1 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. Tennessee Oncology. (n.d.). E. Kirk Barnes, M.D. Retrieved from:

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified July 28, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now